BIOLARGO, INC. (ticker: BLGO) is an OTC-listed chemicals & allied products company. DredgeCap's structured extraction of BLGO's SEC filings surfaces 19 active risk signals, including 18 late-filing signals, and 1 auditor-change signal. BLGO reported $12.23M in revenue and -$3.80M for the period ending 2023-12-31, with operating cash flow of -$8.30M. Cash and equivalents stood at $3.88M (up 9.4% year-over-year). Total assets of $8.31M exceed total liabilities of $6.79M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BLGO SEC Filings
Full cached SEC EDGAR filing history for BLGO, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.